William David Lis

William David Lis

Directeur/Membre du Conseil chez ZAI LAB LIMITED

Fortune : 930 013 $ au 30/06/2026

61 ans
Health Technology
Commercial Services
Consumer Services

Profil

William David Lis is Executive Chairman & Chief Executive Officer at Jasper Tx Corp.
since 2019.
He is Executive Chairman at Tr1x, Inc. starting in 2025.
He serves as Independent Director at Zai Lab Ltd. since 2018.
Former roles include Chief Executive Officer & Director at Portola Pharmaceuticals LLC from 2012 to 2018, Non-Executive Chairman at Jasper Therapeutics, Inc. from 2022 to 2023, Product Director at COR Therapeutics, Inc. from 1999 to 2002, Marketing Director at Millennium Pharmaceuticals, Inc. in 2003, Senior Director-Business Development at Portola Pharmaceuticals LLC in 2005, Director at Biotechnology Innovation Organization, Independent Director at Eidos Therapeutics, Inc. from 2018 to 2021, Vice President-Business Development at Scios, Inc. from 2007 to 2008, and Principal at Ethicon Endo-Surgery, Inc. Education includes undergraduate studies at the University of Maryland.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/06/2026 504 370 ( 0,04% ) 930 013 $ 30/06/2026

Postes actifs de William David Lis

SociétésPosteDébut
ZAI LAB LIMITED Directeur/Membre du Conseil 01/10/2018
Directeur Général 01/12/2019
Président 01/06/2025

Anciens postes connus de William David Lis

SociétésPosteFin
EIDOS THERAPEUTICS, INC. Directeur/Membre du Conseil 26/01/2021
PORTOLA PHARMACEUTICALS, INC. Directeur Général 01/08/2018
Corporate Officer/Principal 01/04/2008
PORTOLA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/08/2005
Sales & Marketing -
Voir l'expérience en détail de William David Lis

Formation de William David Lis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. William David Lis